RVP

RIBAVIRIN MONOPHOSPHATE

Created:	2002-08-09
Last modified:	2011-06-04

Find Related PDB Entry
4 entries where RVP is found as a standalone ligand1 entries where RVP is covalently linked to polymer or other heterogen groups

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	34
Chiral Atom Count	4
Bond Count	35
Aromatic Bond Count	5

2D diagram of RVP

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	RIBAVIRIN MONOPHOSPHATE
Systematic Name (OpenEye OEToolkits)	[(2R,3S,4R,5R)-5-(3-aminocarbonyl-1,2,4-triazol-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl dihydrogen phosphate
Formula	C₈ H₁₃ N₄ O₈ P
Molecular Weight	324.185
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	10.04	O=C(c1ncn(n1)C2OC(C(O)C2O)COP(=O)(O)O)N
SMILES	CACTVS	3.341	NC(=O)c1ncn(n1)[CH]2O[CH](CO[P](O)(O)=O)[CH](O)[CH]2O
SMILES	OpenEye OEToolkits	1.5.0	c1nc(nn1C2C(C(C(O2)COP(=O)(O)O)O)O)C(=O)N
Canonical SMILES	CACTVS	3.341	NC(=O)c1ncn(n1)[C@@H]2O[C@H](CO[P](O)(O)=O)[C@@H](O)[C@H]2O
Canonical SMILES	OpenEye OEToolkits	1.5.0	c1nc(nn1[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O)O)O)C(=O)N
InChI	InChI	1.03	InChI=1S/C8H13N4O8P/c9-6(15)7-10-2-12(11-7)8-5(14)4(13)3(20-8)1-19-21(16,17)18/h2-5,8,13-14H,1H2,(H2,9,15)(H2,16,17,18)/t3-,4-,5-,8-/m1/s1
InChIKey	InChI	1.03	SDWIOXKHTFOULX-AFCXAGJDSA-N

Drug Info: DrugBank

DrugBank ID	DB14663
Name	Ribavirin monophosphate
Groups	experimental
Synonyms	Virazole 5'-phosphate Ribavirin monophosphate Ribavirin 5'-monophosphate
Categories	Anti-Infective Agents Antiviral Agents Carbohydrates Enzyme Inhibitors Glycosides Nucleic Acids, Nucleotides, and Nucleosides
CAS number	40925-28-8

Related Resource References

Resource Name	Reference
PubChem	100252
ChEMBL	CHEMBL1235764

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.